Covis Pharma GmbH
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Feb 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 22, 2027The maintenance fee for Methods of Reducing Risk of Preterm Birth (US 11,730,744) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,371,292 | Use of Ciclesonide for the Treatment of Respiratory Diseases In force · High confidence | In force | High confidence | |
| US 8,481,516 | Ciclesonide containing sterile aqueous suspension In force · High confidence | In force | High confidence | |
| US 8,435,497 | Formoterol and Ciclesonide Combination In force · High confidence | In force | High confidence | |
| US 11,007,150 | Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation In force · High confidence | In force | High confidence | |
| US 11,992,556 | Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation In force · High confidence | In force | High confidence | |
| US 12,370,141 | Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation In force · High confidence | In force | High confidence | |
| US 9,422,327 | Process for preparing crystalline ciclesonide with defined particle size In force · High confidence | In force | High confidence | |
| US 11,154,562 | Methods of Reducing Risk of Preterm Birth In force · Medium confidence | In force | Medium confidence | |
| US 11,304,962 | Methods of Reducing Risk of Preterm Birth In force · Medium confidence | In force | Medium confidence | |
| US 11,730,744 | Methods of Reducing Risk of Preterm Birth In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 10: 4 patents in force now held by others · 7 lapsed for an unpaid fee · 23 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 1 no status recorded